Literature DB >> 23749074

[Pharmacological and clinical profile of bixalomer (Kiklin(®) capsules): a new therapeutic agent for hyperphosphatemia].

Keiichi Taniguchi1, Hirotoshi Kakuta, Yuichi Tomura, Seiji Kaku, Wataru Uchida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23749074     DOI： 10.1254/fpj.141.333

Source DB:  PubMed          Journal:  Nihon Yakurigaku Zasshi        ISSN： 0015-5691


× No keyword cloud information.
  1 in total

1.  Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis.

Authors:  Shingo Hatakeyama; Hiromi Murasawa; Takuma Narita; Masaaki Oikawa; Naoki Fujita; Hiromichi Iwamura; Joutaro Mikami; Yuta Kojima; Tendo Sato; Ken Fukushi; Yusuke Ishibashi; Yasuhiro Hashimoto; Takuya Koie; Hisao Saitoh; Tomihisa Funyu; Chikara Ohyama
Journal:  BMC Nephrol       Date:  2013-10-12       Impact factor: 2.388
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.